Cumberland pharmaceuticals q3 revenue rose 22% to $10.4 million

Cumberland pharmaceuticals reports 22% revenue growth in the third quarter.q3 adjusted earnings per share $0.01.q3 loss per share $0.13.q3 revenue rose 22 percent to $10.4 million.

CPIX Ratings Summary

CPIX Quant Ranking